Wilms' tumor pathophysiology: Difference between revisions
Created page with "{{CMG}} {{Wilms' tumor}} ==Overview== ==Pathology== Pathologically, a triphasic nephroblastoma comprises three elements: * blastema * mesenchyme * epithelium Wi..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | {{CMG}} | ||
{{Wilms' tumor}} | {{Wilms' tumor}} | ||
| Line 4: | Line 5: | ||
==Overview== | ==Overview== | ||
== | ==Pathophysiology== | ||
Pathologically, a triphasic nephroblastoma comprises three elements: | Pathologically, a triphasic nephroblastoma comprises three elements: | ||
* [[ | * [[Blastema]] | ||
* [[ | * [[Mesenchyme]] | ||
* [[ | * [[Epithelium]] | ||
Wilms' tumor is a malignant tumor containing [[metanephric blastema]], stromal and epithelial derivatives. Characteristic is the presence of abortive tubules and glomeruli surrounded by a spindled cell stroma. The stroma may include striated [[muscle]], [[cartilage]], [[bone]], fat tissue, fibrous tissue. The tumor is compressing the normal kidney parenchyma. [http://www.pathologyatlas.ro/Wilms%20Tumor.html Pathology images] | Wilms' tumor is a malignant tumor containing [[metanephric blastema]], stromal and epithelial derivatives. Characteristic is the presence of abortive tubules and glomeruli surrounded by a spindled cell stroma. The stroma may include striated [[muscle]], [[cartilage]], [[bone]], fat tissue, fibrous tissue. The tumor is compressing the normal kidney parenchyma. [http://www.pathologyatlas.ro/Wilms%20Tumor.html Pathology images] | ||
| Line 18: | Line 19: | ||
* ''[[Anaplastic]]'' - Contains diffuse anaplasia (poorly developed cells) | * ''[[Anaplastic]]'' - Contains diffuse anaplasia (poorly developed cells) | ||
== Molecular biology == | ===Molecular biology=== | ||
Mutations of the [[WT1]] gene on chromosome 11 are observed in approximately 20% of Wilms' tumors.<ref>{{cite journal |author=Call K, Glaser T, Ito C, Buckler A, Pelletier J, Haber D, Rose E, Kral A, Yeger H, Lewis W |title=Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus |journal=Cell |volume=60 |issue=3 |pages=509-20 |year=1990 |pmid=2154335}}</ref><ref>{{cite journal |author=Huff V |title=Wilms tumor genetics |journal=Am J Med Genet |volume=79 |issue=4 |pages=260-7 |year=1998 |pmid=9781905}}</ref> At least half of the Wilms' tumors with mutations in WT1 also carry mutations in CTNNB1, the gene encoding the proto-oncogene beta-catenin.<ref>{{cite journal |author=Maiti S, Alam R, Amos CI, Huff V |title=Frequent association of beta-catenin and WT1 mutations in Wilms tumors |journal=Cancer Res |volume=60 |issue=22 |pages=6288-92 |year=2000 |pmid=11103785}}</ref> | Mutations of the [[WT1]] gene on chromosome 11 are observed in approximately 20% of Wilms' tumors.<ref>{{cite journal |author=Call K, Glaser T, Ito C, Buckler A, Pelletier J, Haber D, Rose E, Kral A, Yeger H, Lewis W |title=Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus |journal=Cell |volume=60 |issue=3 |pages=509-20 |year=1990 |pmid=2154335}}</ref><ref>{{cite journal |author=Huff V |title=Wilms tumor genetics |journal=Am J Med Genet |volume=79 |issue=4 |pages=260-7 |year=1998 |pmid=9781905}}</ref> At least half of the Wilms' tumors with mutations in WT1 also carry mutations in CTNNB1, the gene encoding the proto-oncogene beta-catenin.<ref>{{cite journal |author=Maiti S, Alam R, Amos CI, Huff V |title=Frequent association of beta-catenin and WT1 mutations in Wilms tumors |journal=Cancer Res |volume=60 |issue=22 |pages=6288-92 |year=2000 |pmid=11103785}}</ref> | ||
Revision as of 13:29, 17 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Wilms' tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Wilms' tumor pathophysiology On the Web |
|
American Roentgen Ray Society Images of Wilms' tumor pathophysiology |
|
Risk calculators and risk factors for Wilms' tumor pathophysiology |
Overview
Pathophysiology
Pathologically, a triphasic nephroblastoma comprises three elements:
Wilms' tumor is a malignant tumor containing metanephric blastema, stromal and epithelial derivatives. Characteristic is the presence of abortive tubules and glomeruli surrounded by a spindled cell stroma. The stroma may include striated muscle, cartilage, bone, fat tissue, fibrous tissue. The tumor is compressing the normal kidney parenchyma. Pathology images
The mesenchymal component may include cells showing rhabdomyoid differentiation. The rhabdomyoid component may itself show features of malignancy (rhabdomyosarcomatous Wilms).
Wilms tumor may be separated into 2 prognostic groups based on pathologic characteristics:
- Favorable - Contains well developed components mentioned above
- Anaplastic - Contains diffuse anaplasia (poorly developed cells)
Molecular biology
Mutations of the WT1 gene on chromosome 11 are observed in approximately 20% of Wilms' tumors.[1][2] At least half of the Wilms' tumors with mutations in WT1 also carry mutations in CTNNB1, the gene encoding the proto-oncogene beta-catenin.[3]
A gene on the X chromosome, WTX, is inactivated in up to 30% of Wilms' tumor cases, according to research published in 2007.[4]
References
- ↑ Call K, Glaser T, Ito C, Buckler A, Pelletier J, Haber D, Rose E, Kral A, Yeger H, Lewis W (1990). "Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus". Cell. 60 (3): 509–20. PMID 2154335.
- ↑ Huff V (1998). "Wilms tumor genetics". Am J Med Genet. 79 (4): 260–7. PMID 9781905.
- ↑ Maiti S, Alam R, Amos CI, Huff V (2000). "Frequent association of beta-catenin and WT1 mutations in Wilms tumors". Cancer Res. 60 (22): 6288–92. PMID 11103785.
- ↑ Rivera M, Kim W, Wells J, Driscoll D, Brannigan B, Han M, Kim J, Feinberg A, Gerald W, Vargas S, Chin L, Iafrate A, Bell D, Haber D (2007). "An X chromosome gene, WTX, is commonly inactivated in Wilms tumor". Science. 315 (5812): 642–5. PMID 17204608.